
Scorpius Holdings Expands CDMO Operations with New Mammalian Facility
Scorpius Holdings Inc., an integrated contract development and manufacturing organization (CDMO), has announced the expected launch of its first cGMP mammalian manufacturing campaign at its San Antonio facility in the third quarter of 2024. Jeff Wolf, CEO of Scorpius, expressed